PT3864053T - Tratamento de rms por terapia de mudança - Google Patents

Tratamento de rms por terapia de mudança

Info

Publication number
PT3864053T
PT3864053T PT207854407T PT20785440T PT3864053T PT 3864053 T PT3864053 T PT 3864053T PT 207854407 T PT207854407 T PT 207854407T PT 20785440 T PT20785440 T PT 20785440T PT 3864053 T PT3864053 T PT 3864053T
Authority
PT
Portugal
Prior art keywords
rms
treatment
switching therapy
therapy
switching
Prior art date
Application number
PT207854407T
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT3864053T publication Critical patent/PT3864053T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
PT207854407T 2020-01-30 2020-09-10 Tratamento de rms por terapia de mudança PT3864053T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20154736 2020-01-30

Publications (1)

Publication Number Publication Date
PT3864053T true PT3864053T (pt) 2023-09-28

Family

ID=69423077

Family Applications (1)

Application Number Title Priority Date Filing Date
PT207854407T PT3864053T (pt) 2020-01-30 2020-09-10 Tratamento de rms por terapia de mudança

Country Status (1)

Country Link
PT (1) PT3864053T (pt)

Similar Documents

Publication Publication Date Title
GB202020573D0 (en) Novel methods of therapy
IL297268A (en) Therapeutic use of fluromotilins
IL290619A (en) rms treatment by switching treatment
GB202020572D0 (en) Novel methods of therapy
IL304628A (en) Treatment of skin disorders
PT3864053T (pt) Tratamento de rms por terapia de mudança
EP4028389A4 (en) TREATMENT OF TRAUMATIC ENCEPHALOPATHY USING FIBROBLASTS AND THERAPEUTIC ADJUVANTS
EP4121166C0 (en) THERAPEUTIC TREATMENT OF CHROMATINOPATHIES
GB202313014D0 (en) Novel therapeutic treatment
GB202315695D0 (en) TReatment of cariomyopathy
GB202218510D0 (en) Novel therapeutic treatment
GB202212506D0 (en) Treatment of covid-19
GB202020570D0 (en) Novel methods of therapy
GB202118011D0 (en) Methods of treatment
GB202118006D0 (en) Methods of treatment
GB202118007D0 (en) Methods of treatment
GB202108245D0 (en) Methods of treatment
GB202108242D0 (en) Methods of treatment
GB202201819D0 (en) Methods of treatment
GB202201824D0 (en) Methods of treatment
GB202201825D0 (en) Methods of treatment
GB202003803D0 (en) Treatment of limb spasticity
GB202005874D0 (en) Methods of treatment
GB202202167D0 (en) Novel methods of therapy
GB202202170D0 (en) Novel methods of therapy